Skip to main content

Table 1 The characteristics of enrolled patients

From: Elobixibat alleviates chronic constipation in hemodialysis patients: a questionnaire-based study

Variable

Mean ± SD and Median [IQR]

Number of enrolled patients

27

Sex (Male/Female)

18/9

Etiology of end-stage renal disease

Diabetic nephropathy, 12 patients

Nephrosclerosis, 6 patients

CGN, 6 patients

ADPKD, 2 patients

Graft loss, 1 patient

Age (year)

70 ± 13, 75 [57, 80]

Dialysis duration (year)

8 ± 9, 6 [1,11]

Dry weight (kg)

58.1 ± 13.3, 58.1 [53.7, 61.5]

Single pool Kt/V

1.08 ± 0.25, 1.11 [0.86, 1.30]

Concomitant laxative

1 type drug: 13 patients

2 types drugs: 10 patients

3 types drugs: 4 patients

Type of concomitant laxative

Sennosides A and B, 26 patients

Sodium picosulfate hydrate, 5 patients

Glycerine enema, 1 patient

Lactulose, 2 patients

Sodium dihydrogen phosphate/sodium hydrogen carbonate, 2 patients

Lubiprostone, 5 patients

Lactomin, 3 patients

Daikenchuto, 1 patient

Phosphate binder

0 drug, 3 patients

1 type of drug, 15 patients

2 types of drug, 9 patients

Type of phosphate binder

Lantern carbonate, 6 patients

Calcium carbonate, 19 patients

Ferric citrate, 6 patients

Sucroferric oxyhydroxide, 2 patients

  1. CGN chronic glomerulonephritis, ADPKD autosomal dominant polycystic kidney disease